Concepedia

Catherine Sabatos-Peyton

CS

18

Publications

1.6K

Citations

15

H-Index

2009

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

National Cancer Centre Singapore

University of Bristol

The University of Texas MD Anderson Cancer Center

Catherine Sabatos-Peyton is an author at Novartis (United States) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2009–2024

18

Publications

18

Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors

Giuseppe Curigliano, Hans Gelderblom, Nicolas Mach et al. · Clinical Cancer Research · 2021 · 335 citations · Full text

Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy

Bronwen R. Burton, Graham J. Britton, Hai Fang et al. · Nature Communications · 2014 · 182 citations · Full text

Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10–secreting Th1 cells

Leona Gabryšová, Kirsty Nicolson, Heather B. Streeter et al. · The Journal of Experimental Medicine · 2009 · 150 citations · Full text

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies

Patrick Schöffski, Daniel Shao-Weng Tan, Miguel Martín et al. · Journal for ImmunoTherapy of Cancer · 2022 · 147 citations · Full text

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

Simone Bonazzi, Eva d’Hennezel, Rohan E. J. Beckwith et al. · Cell chemical biology · 2023 · 135 citations · Full text

Rows per page

1–5 of 18